PL2285357T3 - Kompozycja farmaceutyczna zawierająca brivaracetam - Google Patents
Kompozycja farmaceutyczna zawierająca brivaracetamInfo
- Publication number
- PL2285357T3 PL2285357T3 PL09753941T PL09753941T PL2285357T3 PL 2285357 T3 PL2285357 T3 PL 2285357T3 PL 09753941 T PL09753941 T PL 09753941T PL 09753941 T PL09753941 T PL 09753941T PL 2285357 T3 PL2285357 T3 PL 2285357T3
- Authority
- PL
- Poland
- Prior art keywords
- brivaracetam
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- MSYKRHVOOPPJKU-BDAKNGLRSA-N brivaracetam Chemical compound CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1 MSYKRHVOOPPJKU-BDAKNGLRSA-N 0.000 title 1
- 229960002161 brivaracetam Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08009919 | 2008-05-30 | ||
| PCT/EP2009/056570 WO2009144286A1 (en) | 2008-05-30 | 2009-05-28 | Pharmaceutical compositions comprising brivaracetam |
| EP09753941.5A EP2285357B8 (en) | 2008-05-30 | 2009-05-28 | Pharmaceutical compositions comprising brivaracetam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2285357T3 true PL2285357T3 (pl) | 2014-08-29 |
Family
ID=39714168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09753941T PL2285357T3 (pl) | 2008-05-30 | 2009-05-28 | Kompozycja farmaceutyczna zawierająca brivaracetam |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8435564B2 (pl) |
| EP (1) | EP2285357B8 (pl) |
| JP (1) | JP5553452B2 (pl) |
| CN (1) | CN102046153B (pl) |
| BR (1) | BRPI0912161A2 (pl) |
| CA (1) | CA2722093C (pl) |
| DK (1) | DK2285357T3 (pl) |
| ES (1) | ES2465478T3 (pl) |
| PL (1) | PL2285357T3 (pl) |
| WO (1) | WO2009144286A1 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011135430A1 (en) | 2010-04-29 | 2011-11-03 | Lupin Limited | Controlled release pharmaceutical compositions of brivaracetam |
| US9675603B2 (en) * | 2010-09-21 | 2017-06-13 | Intekrin Therapeutics, Inc. | Solid pharmaceutical compositions of ppary modulator |
| CN109069480A (zh) | 2015-12-30 | 2018-12-21 | 阿达玛斯医药公司 | 用于治疗与癫痫相关的病症的方法和组合物 |
| AU2018280866A1 (en) * | 2017-06-09 | 2019-12-12 | Zoetis Broomhill Ip Limited | Intramammary veterinary composition |
| WO2019046611A1 (en) * | 2017-08-31 | 2019-03-07 | Purdue Pharma L.P. | PHARMACEUTICAL DOSAGE FORMS |
| CN109833300A (zh) * | 2017-11-28 | 2019-06-04 | 浙江京新药业股份有限公司 | 一种抗癫痫药物口服组合物及其制备方法 |
| CN110638743B (zh) * | 2019-10-25 | 2023-03-28 | 乐普制药科技有限公司 | 一种含布立西坦的组合物 |
| CN111407738A (zh) * | 2020-04-03 | 2020-07-14 | 江苏艾立康药业股份有限公司 | 一种布立西坦控释制剂及其制备方法 |
| CN118267385A (zh) | 2020-07-09 | 2024-07-02 | 上海云晟研新生物科技有限公司 | 一种布瓦西坦药物组合物、其制备方法及应用 |
| CN114146062B (zh) * | 2021-03-17 | 2023-07-28 | 长沙晶易医药科技有限公司 | 一种组合物及其制备方法和用途 |
| CN115192572B (zh) * | 2021-04-08 | 2023-09-19 | 成都同道慧宜生物医药科技有限公司 | 布立西坦药剂、其制备方法和应用 |
| CN115721624A (zh) * | 2021-08-25 | 2023-03-03 | 北京海美源医药科技有限公司 | 一种布立西坦药物组合物及其制备方法和其应用 |
| US12133918B2 (en) | 2021-10-01 | 2024-11-05 | Griffin Gamma, Llc | Partially pre-gelatinized cassava starch as pharmaceutical excipient |
| US20250064780A1 (en) * | 2021-12-27 | 2025-02-27 | Sunshine Lake Pharma Co., Ltd. | Brivaracetam tablet and preparation method therefor |
| CN118416004A (zh) | 2023-02-02 | 2024-08-02 | 泰州越洋医药开发有限公司 | 一种布立西坦双释三层片及其制备方法 |
| EP4491176A1 (en) * | 2023-07-14 | 2025-01-15 | Sanovel Ilac Sanayi ve Ticaret A.S. | A film coated tablet comprising brivaracetam |
| EP4491177A1 (en) * | 2023-07-14 | 2025-01-15 | Sanovel Ilac Sanayi ve Ticaret A.S. | Film coated tablets of brivaracetam |
| EP4559456A1 (en) * | 2023-11-22 | 2025-05-28 | Sanovel Ilac Sanayi ve Ticaret A.S. | A modified release tablet of brivaracetam |
| TR2023015500A1 (tr) * | 2023-11-22 | 2025-06-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bri̇varasetam i̇çeren deği̇şti̇ri̇lmi̇ş salimli bi̇r tablet kompozi̇syonu |
| EP4559457A1 (en) * | 2023-11-22 | 2025-05-28 | Sanovel Ilac Sanayi ve Ticaret A.S. | A modified release tablet composition of brivaracetam |
| TR2023015501A1 (tr) * | 2023-11-22 | 2025-06-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bri̇varasetam i̇çeren deği̇şti̇ri̇lmi̇ş salimli bi̇r tablet |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9518953D0 (en) * | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| RU2346996C2 (ru) | 2004-06-29 | 2009-02-20 | ЮРОПИЭН НИКЕЛЬ ПиЭлСи | Усовершенствованное выщелачивание основных металлов |
| EA014249B1 (ru) * | 2005-01-27 | 2010-10-29 | Алембик Лимитед | Формуляция леветирацетама длительного высвобождения |
| WO2006090275A1 (en) * | 2005-02-24 | 2006-08-31 | Pfizer Limited | Treatment of incontinence |
| KR101280096B1 (ko) | 2005-06-29 | 2013-06-28 | 컴퓨메딕스 리미티드 | 전도성 브리지를 포함하는 센서 어셈블리 |
| TW200735878A (en) * | 2005-11-18 | 2007-10-01 | Astrazeneca Ab | Pharmaceutical compositions |
| AR057946A1 (es) * | 2005-11-28 | 2007-12-26 | Orexigen Therapeutics Inc | Formulacion de zonisamida de liberacion sostenidda |
| US8338621B2 (en) * | 2005-12-21 | 2012-12-25 | Ucb S.A. | Process for the preparation of 2-oxo-1-pyrrolidine derivatives |
| CA2635949A1 (en) * | 2006-01-11 | 2007-07-19 | Teva Pharmaceutical Industries Ltd. | Controlled release formulation of divalproic acid and its derivatives |
| EP2041084B1 (en) * | 2006-06-08 | 2013-11-06 | UCB Pharma, S.A. | Co-crystals of pyrrolidinones |
| JP2006335771A (ja) * | 2006-09-22 | 2006-12-14 | Takeda Chem Ind Ltd | 徐放性製剤およびその製造方法 |
| EP2081563A1 (en) * | 2006-10-12 | 2009-07-29 | Abbott Laboratories | Pharmaceutical formulations |
-
2009
- 2009-05-28 CA CA2722093A patent/CA2722093C/en active Active
- 2009-05-28 ES ES09753941.5T patent/ES2465478T3/es active Active
- 2009-05-28 US US12/993,704 patent/US8435564B2/en active Active
- 2009-05-28 DK DK09753941.5T patent/DK2285357T3/da active
- 2009-05-28 PL PL09753941T patent/PL2285357T3/pl unknown
- 2009-05-28 EP EP09753941.5A patent/EP2285357B8/en not_active Revoked
- 2009-05-28 CN CN200980120221.XA patent/CN102046153B/zh active Active
- 2009-05-28 JP JP2011511013A patent/JP5553452B2/ja active Active
- 2009-05-28 BR BRPI0912161A patent/BRPI0912161A2/pt not_active IP Right Cessation
- 2009-05-28 WO PCT/EP2009/056570 patent/WO2009144286A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2722093A1 (en) | 2009-12-03 |
| EP2285357B1 (en) | 2014-05-07 |
| HK1153141A1 (en) | 2012-03-23 |
| ES2465478T8 (es) | 2014-08-22 |
| CA2722093C (en) | 2015-04-28 |
| CN102046153A (zh) | 2011-05-04 |
| US20110091547A1 (en) | 2011-04-21 |
| CN102046153B (zh) | 2015-06-17 |
| EP2285357A1 (en) | 2011-02-23 |
| ES2465478T3 (es) | 2014-06-05 |
| EP2285357B8 (en) | 2014-07-23 |
| JP5553452B2 (ja) | 2014-07-16 |
| WO2009144286A1 (en) | 2009-12-03 |
| DK2285357T3 (da) | 2014-06-02 |
| BRPI0912161A2 (pt) | 2015-10-06 |
| JP2011521927A (ja) | 2011-07-28 |
| US8435564B2 (en) | 2013-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2285357T3 (pl) | Kompozycja farmaceutyczna zawierająca brivaracetam | |
| GB0814695D0 (en) | Pharmaceutical compositions | |
| PL2323623T3 (pl) | Kompozycje farmaceutyczne | |
| IL247741A0 (en) | pharmaceutical preparations | |
| IL228817A0 (en) | Pharmaceutical compounds | |
| EP2222313A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| ZA201102715B (en) | Solid pharmaceutical composition | |
| IL208387A0 (en) | Pharmaceutical composition | |
| GB0707127D0 (en) | Pharmaceutical compositions | |
| EP2146695A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB0709811D0 (en) | Pharmaceutical compositions | |
| ZA201100871B (en) | Solid pharmaceutical composition | |
| ZA201006224B (en) | Pharmaceutical composition | |
| IL206487A0 (en) | Pharmaceutical compositions | |
| GB2464200B (en) | Pharmaceutical composition | |
| GB0712454D0 (en) | Pharmaceutical compositions | |
| GB0817969D0 (en) | Pharmaceutical composition | |
| GB0800659D0 (en) | Pharmaceutical Compositions | |
| GB2454923B (en) | Pharmaceutical compositions | |
| EP2236135A4 (en) | STABLE PHARMACEUTICAL COMPOSITION | |
| IL201394A0 (en) | Niacin - based pharmaceutical compositions | |
| GB0806283D0 (en) | Pharmaceutical compositions | |
| GB0802024D0 (en) | Pharmaceutical compositions | |
| GB0806156D0 (en) | Pharmaceutical compositions | |
| EP2308842A4 (en) | PHARMACEUTICAL COMPOSITIONS |